Sacubitril & ValsartanNeprilysin Inhibitor & Angiotensin Receptor Blocker (Cardiovascular Preparations) Indication: Indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure and reduced ejection fraction. Dosage & Administration: The recommended starting dose is 49/51 mg (Sacubitril/Valsartan) twice-daily. A starting dose of 24/26 mg (Sacubitril/Valsartan) twice-daily is […]